Waste

Novartis is committed to keep the environmental impact from waste at a minimum and follows a clear waste management strategy. The aim is to prevent, reduce, recycle or use waste as an energy source, before selecting safe disposal as an option. Waste prevention and reduction is always preferred to treatment, incineration or disposal. This helps ensure the overall environmental impact related to waste remains minimal, while energy use from waste is maximized. All Novartis sites report waste data on a quarterly basis and our waste contractors are routinely audited to help ensure our waste is properly managed.

We currently recycle approximately 80% of all non-hazardous waste and 60% of all hazardous waste and continue to maximize opportunities for reuse and recycling. We are also making progress toward eliminating single-use plastics in all our workplaces by 2021, with 71 of our sites having already achieved this goal to date.

2025

Eliminate polyvinyl chloride (PVC) in packaging and reduce waste disposal by half versus 2016 levels.

2030

Be plastic neutral with all new products meeting sustainable design principles.

Brian Clarke, PhD, Musculoskeletal

Repackaging medicine

Plastic, especially PVC, has been used for decades to safely package and deliver medicines around the world .We are  now thinking outside the box to find new ways of sustainably packaging medicines.

Read More
Mara Fornaro, Musculoskeletal

At the Novartis site in Cambe, Brazil, a unique recycling project using raw material from blister packaging could set a precedent across the company.

Read More
Olivier Leupin, Musculoskeletal

Two projects, aiming to revolutionize early drug discovery, could also help reduce hazardous waste.

Read More

Source URL: https://www.novartis.com/esg/environmental-sustainability/waste

List of links present in page